Insulin degludec Subcutaneous and Mogamulizumab-kpkc Intravenous
Determining the interaction of Insulin degludec Subcutaneous and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Molindone
- Insulin degludec Subcutaneous-Mometasone (Oral Inhalation)
- Insulin degludec Subcutaneous-Mometasone and Formoterol
- Insulin degludec Subcutaneous-Mometasone and formoterol Inhalation
- Insulin degludec Subcutaneous-Mometasone Cream
- Insulin degludec Subcutaneous-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Insulin detemir
- Mogamulizumab-kpkc Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Mogamulizumab-kpkc Intravenous-Insulin Detemir (Vials)
- Mogamulizumab-kpkc Intravenous-Insulin detemir Subcutaneous
- Mogamulizumab-kpkc Intravenous-Insulin glargine
- Mogamulizumab-kpkc Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens